Owkin vs Recursion: Which AI Tool is Better in 2026?

Owkin is built for ai healthcare, wellness & medical users on a free tier plan, while Recursion targets ai healthcare, wellness & medical workflows on a free tier model — here's how they stack up feature by feature.

Share
Owkin compared with Recursion
ComparisonOwkinRecursion
Pricing & free tierFreemiumFreemium
Starting priceFree, paid plans availableFree, paid plans available
Free trial / creditsExact allowance not recordedExact allowance not recorded
Credit card requiredNo credit card requiredNo credit card required
Foundation modelMulti-modelFine-tuned
BYOK / platform control
BYOK supported
Locked
Category & tagsAI Healthcare, Wellness & MedicalAI Healthcare, Wellness & Medical
Core features & strengths
  • Patient Data Network: access to a large network of multimodal, longitudinal patient data drawn from many hospitals
  • K Pro AI Scientist: an autonomous AI system combining multiple agents, tools, and skills across the drug development pipeline
  • Autopilot or co-pilot modes: K Pro can work independently or alongside human researchers
  • Wet lab validation: organoid and chemistry experiments validate AI-generated hypotheses
  • AI-enabled drug discovery platform: combines automated lab experiments with machine learning models
  • Lab-in-the-loop system: a continuous cycle connecting physical automation and computational analysis
  • Design-Make-Test-Learn process: integrated workflow from biology insight to molecule design to testing
  • Disease-specific cellular engineering: used to generate high-dimensional biological data
Community rating4.5(0)4.5(0)
Get startedVisit Owkin Visit Recursion

The Verdict: Which Should You Choose?

👉 Choose Owkin if you need…

  • People who spend real hours each week on ai healthcare, wellness & medical
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option
Try Owkin

👉 Choose Recursion if you need…

  • Anyone replacing a manual ai healthcare, wellness & medical process with something faster
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option
Try Recursion

Detailed tool breakdown

Owkin

Owkin is an AI biotechnology company focused on accelerating drug discovery and research in medicine. It combines a large network of patient data, an autonomous AI scientist called K Pro, and wet lab validation to help generate and test biological hypotheses. Owkin works with biopharma companies on questions across oncology, neuroscience, cardiology, stroke, pulmonary disease, obesity, and ageing research. The tool is aimed at pharmaceutical companies, research institutions, and biomedical scientists looking to speed up drug R&D using AI combined with real patient data and lab validation, rather than individual consumers or general businesses.

Core use case & workflow

  • Our vision is a world where R&D is automated and research is directly connected to care. Discover how Owkin's AI Scientist is making this a reality.
  • Patient Data Network: access to a large network of multimodal, longitudinal patient data drawn from many hospitals
  • K Pro AI Scientist: an autonomous AI system combining multiple agents, tools, and skills across the drug development pipeline
  • Autopilot or co-pilot modes: K Pro can work independently or alongside human researchers
  • Wet lab validation: organoid and chemistry experiments validate AI-generated hypotheses
  • Feedback loop: validation results feed back into K Pro as reusable workflows for future research
  • Open research questions: Owkin publicly tracks progress on specific medical questions across disease areas

Listed specifications & control

  • Primary category: AI Healthcare, Wellness & Medical.
  • Listed foundation model: Multi-model. Model availability can depend on the selected plan.
  • The listing reports support for your own API key. Check which features use it and whether platform fees still apply.

Strengths in context

  • No separate strengths have been documented for this listing. Use the stated features above as a test checklist rather than treating an undocumented capability as a benefit.

Limitations & practical checks

  • No specific limitations are recorded for this tool. This is not evidence that it has none: test the output quality, export options and usage limits against your actual task.

Pricing realities

  • Directory pricing classification: Freemium. This label alone does not establish an exact allowance or subscription price.
  • Listed starting price: Free, paid plans available. Confirm billing cadence, taxes and included usage before paying.
  • The listing does not document an exact free allowance or trial duration.
  • The listing states that no credit card is required.

Recursion

Recursion is a biotechnology company that uses an AI-driven platform to discover and develop new medicines. It combines automated wet-lab experiments with machine learning models in what it calls a "lab-in-the-loop" system, mapping disease biology, designing drug candidates, and advancing them toward clinical trials. The company maintains its own pipeline of investigational drugs in areas like oncology and rare disease, and also partners with pharmaceutical companies to apply its technology to specific drug discovery challenges. This is not a consumer software product but a platform and company aimed at pharmaceutical partners, investors, and researchers interested in AI-driven biology and drug development, rather than individual end users seeking a subscription tool.

Core use case & workflow

  • Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us today!
  • AI-enabled drug discovery platform: combines automated lab experiments with machine learning models
  • Lab-in-the-loop system: a continuous cycle connecting physical automation and computational analysis
  • Design-Make-Test-Learn process: integrated workflow from biology insight to molecule design to testing
  • Disease-specific cellular engineering: used to generate high-dimensional biological data
  • Molecule narrowing: uses its system to reduce millions of candidate molecules to a synthetically accessible shortlist
  • Clinical pipeline: wholly owned programs spanning oncology and rare disease indications
  • Pharma partnerships: collaborates with partners to target specific therapeutic challenges

Listed specifications & control

  • Primary category: AI Healthcare, Wellness & Medical.
  • Listed foundation model: Fine-tuned. Model availability can depend on the selected plan.
  • Managed platform: the listing reports no support for bringing your own API key.

Strengths in context

  • No separate strengths have been documented for this listing. Use the stated features above as a test checklist rather than treating an undocumented capability as a benefit.

Limitations & practical checks

  • No specific limitations are recorded for this tool. This is not evidence that it has none: test the output quality, export options and usage limits against your actual task.

Pricing realities

  • Directory pricing classification: Freemium. This label alone does not establish an exact allowance or subscription price.
  • Listed starting price: Free, paid plans available. Confirm billing cadence, taxes and included usage before paying.
  • The listing does not document an exact free allowance or trial duration.
  • The listing states that no credit card is required.

How to choose for your workflow

Compare finished work, not the first response

Give both tools the same brief and source material. Judge the final deliverable after corrections: factual accuracy, editable output, and how much work remains before you can use it.

Price the complete workflow

Count retries, exports, premium models and any separate hosting or API charges. A free allowance is useful for evaluation, but it does not establish the cost of a recurring production workload.

Check control and portability

Confirm which files, project data and settings you can export. Bringing your own API key is different from owning the application code or being able to run the product independently.

Validate rights and sensitive data

Check the terms for the exact plan and feature you intend to use. Commercial permission, private projects and protection against intellectual property claims are different commitments.